Marker Therapeutics, Inc. Gains 34.85%
Wed, May 31, 2023 at 07:47 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) jumped higher at $1.78, representing a gain of 34.8%. On Wed, May 31, 2023, MRKR:NASDAQ touched a New 2-Week High of $1.78. The stock got featured on our News Catalysts scanner on Wed, May 31, 2023 at 08:23 AM in the 'BIOTECH' category. From Wed, May 17, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- SunCar Technology Group Inc Ord (SDA:NASDAQ), 120.88%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 114.81%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 34.85%
- Inventiva S.A. (IVA:NASDAQ), 31.5%
- VIQ Solutions Inc. (VQS:NASDAQ), 28.76%
- Peak Bio Inc Com (PKBO:NASDAQ), 26.41%
- Bright Green Corporation (BGXX:NASDAQ), 24.01%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.96%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 22.88%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 22.59%